AA
Andreas Argyrides Oppenheimer Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
16%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
89.7%
Neutral
6.9%
Negative
3.4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $600 |
22%
upside
| 2 | +16% |
0
%
| 26 Feb ‘26 6 days ago |
|
|
|
Outperform
Maintained
| $35 |
95%
upside
| 1 | -3.9% |
0
%
| 24 Feb ‘26 8 days ago |
|
|
|
Outperform
Initiated
| $42 |
76%
upside
| 1 | +27% |
0
%
| 22 Jan ‘26 1 month ago |
|
|
|
Outperform
Upgraded
| $40 |
158%
upside
| 5 | +3.8% |
0
%
| 10 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $9 |
57%
upside
| 2 | +24% |
0
%
| 14 Nov ‘25 3 months ago |
|
|
|
Outperform
Reiterated
| $27 |
99%
upside
| 1 | -20% |
0
%
| 12 Nov ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $115 |
111%
upside
| 2 | +57% |
0
%
| 2 Oct ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $21 |
282%
upside
| 1 | +31% |
0
%
| 2 Oct ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $29 |
164%
upside
| 1 | -19% |
0
%
| 16 Sep ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $33 |
9,264%
upside
| 2 | +106% |
0
%
| 11 Sep ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $15 |
414%
upside
| 1 | -45% |
0
%
| 5 Sep ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $20 |
298%
upside
| 2 | -7.3% |
0
%
| 15 Aug ‘25 6 months ago |
|
|
|
Outperform
Assumed
| $61 |
112%
upside
| 1 | -17% |
0
%
| 2 Jun ‘25 9 months ago |
|
|
|
Outperform
Assumed
| $7 |
61%
upside
| 1 | +59% |
0
%
| 2 Jun ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $3 |
220%
upside
| 2 | -12% |
0
%
| 29 May ‘25 9 months ago |
|
|
|
Underperform
Downgraded
| $13 |
61%
downside
| 1 | -78% |
0
%
| 19 May ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $4 |
194%
upside
| 1 | +140% |
0
%
| 16 May ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $90 |
690%
upside
| 1 | -30% |
0
%
| 13 May ‘25 9 months ago |
|
|
|
Outperform
Maintained
| $9 |
442%
upside
| 1 | +3.1% |
0
%
| 13 May ‘25 9 months ago |
|